Catégorie : Institutions, Service Providers & others

BIOVALLEY FRANCE

by jbertholdin Institutions, Service Providers & others

BIOVALLEY FRANCE

About the company

Based in Eastern France, the BioValley France cluster brings to the health sector its unique expertise and personalized support around 4 fields of expertise: Drugs and Innovative Therapies, E-health, Medical Technologies and Diagnosis. For more than eighteen years, BioValley France has built a powerful community in order to deploy a strong network mixing academics and industrials in the health sector: more than 300 members and partners have decided to join the Cluster in order to share, exchange and develop tomorrow’s innovation in the best conditions. BioValley France offers services in: Business Competitiveness, Innovative Project, International Relations, Visibility and Influence.

About the solution

For more than eighteen years, BioValley France has built a powerful community in order to deploy a strong network mixing academics and industrials in the health sector: more than 300 members and partners have decided to join the Cluster in order to share, exchange and develop tomorrow’s innovation in the best conditions.

Website
Key information

–  Therapeutic areas: Medical Device, E-health, Biotherapy

–  Based in: Strasbourg (FRANCE)

–  Employees: 11 – 50

–  Created in: 2002

ERBC GROUP

by jbertholdin Institutions, Service Providers & others

ERBC GROUP

About the company

ERBC group is a leader in discovery and non-clinical studies, offering to healthcare and chemical professionals a comprehensive range of discovery and preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity.

About the solution

At ERBC Group, THEY STRATEGIZE your approach to make your drug development a SUCCESS:
– Build on most relevant translational models
– Select best predictive biomarkers
– Choose state-of-the-art technologies.

Website
Key information

–  Therapeutic areas: Oncology – Cancer, Immunology, Inflammation, Neurology – Neurosciences, Cell and gene therapies, Cardiovascular, Infectious diseases, Metabolic diseases – Hepatology – Diabetes, Gastroenterology, Respiratory, Ophthalmology, Allergy, Dermatology, Orthopedics, Central nervous system, Nephrology, Cardiology, Pulmonology, Endocrinology, Hematology

–  Based in: Baugy, Toulouse, Lyon, Orleans (FRANCE)

–  Employees: 201-500

–  Created in: 2019

OXELTIS

by jbertholdin Institutions, Service Providers & others

OXELTIS

About the company

Oxeltis is a medicinal chemistry services company created in 2010 in Montpellier, France, by former researchers from Idenix Pharmaceuticals (formerly MSD). The company has a small-scale custom synthesis business and hit and lead optimization services in various areas, such as antivirals, antibiotics, and anticancer compounds. Oxeltis’ scientific team comprises 21 experienced chemists with recognized expertise in specific areas of organic synthesis: heterocycles, macrocycles, nucleosides/nucleotides, phosphoramidites, iminosugars, modified sugars, oligosaccharides, and PROTACs. Oxeltis services includes also route scouting and up to 50-100g synthesis. Oxeltis works with European, Japanese, and North American start-ups, pharma companies, and research institutions.

About the solution

Oxeltis team is focused on speed of delivery, quality, and confidentiality of the services and collaborations it develops. Oxeltis has completed more than 35 projects with complex and multi-step synthetic chemistry for pharmaceutical and biotechnology companies, including five of the ten largest global pharmaceutical companies. Several drug candidates delivered to its customers are in clinical development.

Website
Key information

–  Therapeutic areas: Infectious diseases, antivirals, antibacterials, Oncology, Neurology, CNS

–  Based in: Montpellier (FRANCE)

–  Employees: 11 – 50

–  Created in: 2010

INOVOTION

by jbertholdin Institutions, Service Providers & others

INOVOTION

About the company

Inovotion is a breakthrough in vivo platform without animal experimentation-3Rs with multiple value creation applications in Drug Discovery and Personalize Medicine.

Inovotion’s Drug Discovery solution, for anticancer drugs including Immuno-Oncology, deliver faster results, higher sensitivity, strong reliability, and very large cost savings. By eliminating low-value molecules, Inovotion accelerates the drug discovery process and significantly reduces its costs and the animal use. Inovotion has carried out over 650 in vivo studies for over 130 customers in Pharma and Biotech in Europe, USA, and Asia.


Inovotion develops new applications for Personalized Medicine, based on a unique assay to grow tumor avatars derived from patients’ Organoids, Biopsies or Circulating Tumor Cells (CTCs).
Inovotion has so far self-financed the development of its multi-function platform though a successful CRO business (over 45% growth in 2023).
Inovotion is now seeking a powerful partner to accelerate its development and disseminate throughout the Biopharma industry in USA and Europe.

About the solution

Inovotion’s Drug Discovery solution is tailored for anticancer drugs, including those in Immuno-Oncology. It provides quicker outcomes, enhanced sensitivity, exceptional reliability, and substantial cost reductions compared to traditional models. By weeding out molecules of low potential, Inovotion expedites the drug discovery journey, drastically cutting down on expenses and the need for animal testing.

Their next generation of in vivo efficacy and toxicity tests:
#EFFICACY of oncology or immuno-oncology drugs
#EARLY TOXICITY assays
#TARGET VALIDATION in oncology
#MULTI-CANCER SCREENING to (re)position
#MECHANISM OF ACTION (angiogenesis, fibrosis, immune cell infiltration, transciptomic, PK,…)
INOVOTION has also developed news assay dedicated to the evaluation of biomaterial.

Website
Key information

–  Therapeutic areas: Oncology, Immuno-Oncology

–  Based in: Gières (FRANCE)

–  Employees: 11 – 50

–  Created in: 2015

DIVA EXPERTISE

by jbertholdin Institutions, Service Providers & others

DIVA EXPERTISE

About the company

DIVA Expertise offers an integrated service offering combining advice, studies and research and an innovative concept of “Turnkey R&D Project” whose general objective is to provide manufacturers with solutions and optimizations to their budget, deadline and production issues. Thanks to its expertise in adipose tissue, DIVA. Expertise supports manufacturers in identifying new action targets for their products and in developing a new scientific argument to help them differentiate themselves from existing competition.

About the solution

DIVA Expertise is a Contract Research Company (CRO) organized, to date, around five activities:


1) DIVA Conseils & Expertise: Scientific advice and expertise to support manufacturers in the management and coordination of research projects and in the valorization of the results of their research through the writing of scientific publications in international journals. reading committee.


2) DIVA Tests & Studies: carrying out preclinical tests and studies using innovative and scientifically validated human adipocyte models to provide the first scientific evidence of the effectiveness of an active ingredient or a finished product and to characterize its effects biological and its mode of action.


3) DIVA R&D: the company carries out internal research activity to develop study models that are ever closer to living things and adapted to the needs of manufacturers.


4) DIVA Biological Resources: the preparation and provision of biological resources to industrial or academic research teams.


5) DIVA Analyzes: analyzes of adipose tissue taken directly from volunteer or sick subjects participating in clinical research protocols.

Website
Key information

–  Therapeutic areas: Cosmetic, Nutraceutical

–  Based in: Toulouse (FRANCE)

–  Employees: 1 – 10

–  Created in: 2016

INOVARION

by jbertholdin Institutions, Service Providers & others

INOVARION

About the company

Inovarion is a Life Sciences company based in Paris offering preclinical and fundamental research services.

Since 2013, Inovarion provides support to the pharmaceutical, biotechnology industries and academics in the form of research services outsourced on a contract basis. They help biotech companies to reach clinical trials faster outsourcing their R&D to Inovarion in France.

They have been working as an extension of their partners’ teams for Sanofi, L’Oréal, Inserm (French NIH), Gustave Roussy, and many more.

About the solution

Inovarion has developed a strong expertise in bioinformatics, oncology, immunology and molecular biology.
They are well established in the research landscape in France and published +140 scientific papers in the highest ranked reviews (Nature, Science, The Lancet, Cell…).

Here are their main advantages:
⁃ Scientific French excellence
⁃ Cost effectiveness thanks to French tax credits : 25%-40% less vs US project cost
⁃ Talent loyalty & stability: less than 5% staff turnover per year in our team

Their goal is to build up close and long-term cooperation with pharmaceutical and biotechnologiy companies worldwide, to offer them in France, very attractive conditions, both financial and time-saving, for conducting top-notch fundamental and preclinical research and beyond that, to achieve together scientifical victories in medicine.

Website
Key information

–  Therapeutic areas: Immuno-oncology, Neuroscience, Dermatology, Oncology, Immunology

–  Based in: Paris (FRANCE)

–  Employees: 51-200

–  Created in: 2013

ETAP-LAB

by jbertholdin Institutions, Service Providers & others

ETAP-LAB

About the company

ETAP-Lab is a preclinical CRO renowned for its expertise in the fields of dermatology, neurology, cardiology and gastroenterology. It assesses the effectiveness of drug candidates and medical devices.

Founded in 1991, ETAP-Lab has now worked with 150 companies ranging from small biotechs to large pharmaceutical groups, both in France and further afield. Ever since the company’s earliest days, ETAP-Lab models have consistently offered high translational value associated with relevant protocols. Mainly comprised of scientific experts, our team analyses client requirements, offering guidance and advice in the development of a tailor-made solution.

ETAP-Lab studies are conducted to exacting quality standards, ensuring the reproducibility, transparency and traceability of tests while maintaining responsiveness and offering regular dialogue with our project managers.

About the solution

ETAP-Lab can fast-track your pipeline with preclinical excellence having high predictability level through in vitro and in vivo testing and rodent behavioural analysis:

– DERMATOLOGY: Wide portfolio of original inflammatory (psoriasis, atopic dermatitis) and wound-healing in vivo models.

– CARDIOLOGY: In-depth in vivo studies of major cardiovascular diseases like Pulmonary Arterial Hypertension, Ischemia Reperfusion, and Heart failures.

– NEUROLOGY: Original and translational in vivo and in vitro models of Stroke and neurodegenerative diseases like Alzheimer’s and Parkinson’s models.

– GASTROENTEROLOGY: In vivo models of gastrointestinal disorders like irritable bowel syndrome (IBS) and traveler’s diarrhea. Expertise in metabolic disturbances such as diabetes, obesity, and malnutrition.

Website
Key information

– Therapeutic areas: Dermatology, Neurology, Cardiology, Gastroenterology, Metabolism

– Based in: Production sites in France

– Employees: 11 – 50

– Created in: 1991

CLINSEARCH

by jbertholdin Institutions, Service Providers & others

CLINSEARCH

About the company

ClinSearch is a full service European CRO, established in 1999, offering clinical research and medical evaluation services throughout Europe, as well as the Middle East and the United States.

They have conducted hundreds of studies, from phase I to IV studies, early access programs, post-marketing studies, RWE, PASS, PAES, database analyses and medico-economic studies, involving 1 patient up to 220,000 subjects.
Their customers include global and local medical device, biotechnology and pharmaceutical companies, as well as public health institutions.

About the solution

Full service offering from A to Z: methodological input to study design through to peer-reviewed publications, passing via in-house development of sophisticated healthcare tools (EDC, ePRO, …).

The in-house team of over 70 people work from our headquarters in Malakoff (France), but hail from ~15 different countries and speak over 10 languages, and are trained to a high standard (MD, PhD, PharmD, MS, MPH …).

Website
Key information

–  Therapeutic areas: Addiction, Aesthetics, Algorithm, Software, Cardiovascular, Dermatology, Fertility, Immunology, Infectiology, Hematology, Neurology, Neuromuscular, Neurovascular, Nursing care, Orthopedic, Oncology, Rheumatology, Rare diseases, Respiratory, Surgery, Urology

–  Based in: Boston (USA)

–  Employees: 51-200

–  Created in: 1999

IRIS PHARMA

by jbertholdin Institutions, Service Providers & others

IRIS PHARMA

About the company

Iris Pharma is a world-leading Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology. Since 1989, they have been offering ophthalmologic drug and device development services to pharmaceutical and biotechnology companies worldwide.

Their focus on the eye allows us to be at the forefront of this field and to help our clients to pass their product through the testing and regulatory process in a rapid and cost-effective manner, allowing them to market their drug and device faster.

At Iris Pharma, quality is a state of mind. Their Quality Assurance program is designed to ensure that your studies are performed in compliance with GLP, GCLP and ICH-GCP requirements, guidelines (FDA, OECD, etc) and local regulatory laws.

About the solution

The CRO has expertise in all ophthalmic indications – from the ocular surface to the posterior segment of the eye – and supports customers, newcomers or experts in ophthalmology, ranging from small start-up companies to large pharmaceutical companies in moving forward products that directly or indirectly affect eye health.

In addition to a wide portfolio of services such as proof of concept studies in animal models, GLP preclinical studies, clinical trials and post-market studies, bioanalytical testing, cellular and molecular biology assays, Iris Pharma also offer consulting services to help customers determine the best indication and the best route for molecules and products in development.

To support more than 400 customers worldwide, Iris Pharma maintain a GLP-accredited laboratory for preclinical research and bioanalytical testing and conducts high-quality clinical trials in accordance with ICH GCP guidelines.

Website
Key information

–  Therapeutic areas: Ophthalmology

–  Based in: La Gaude (FRANCE)

–  Employees: 11 – 50

–  Created in: 1989

B2G LIFE SCIENCES

by jbertholdin Institutions, Service Providers & others

B2G LIFE SCIENCES

About the company

B2G Life Sciences is a science-driven, international, medical consulting company, dedicated to clinical development.
They serve as acting CMO, yet also provide extended stand-alone as well as fully-integrated services, to the biotechnology and pharmaceutical industry, with a particular focus on rare and orphan diseases, oncology, as well as biotherapies and advanced therapies.

They have operational capacities across Europe and the Mediterranean region, as we endeavor to build bridges and gateways between operators in different markets.

About the solution

They serve as acting CMO and provide extended stand-alone as well as fully-integrated consulting services to the biotechnology and pharmaceutical industry, with a particular focus on rare and orphan diseases, oncology,
as well as biotherapeutics and advances therapies.

From study design to execution, they provide services in the following focus areas:
– Clinical development strategies and protocol development
– Management of scientific boards
– Study conduct and patient enrollment
– Medical review and medical writing
– Trainings in the busnisses of biotech and pharma industries.

Website
Key information

–  Therapeutic areas: Clinical Development Consulting services, Rare diseases, Oncology, Biotherapies, Advanced therapies

–  Based in: Sèvres (FRANCE)

–  Employees: 11 – 50

–  Created in: 2011